AVBCC COVID-19 Webcast Series
Large community care centers remain committed to providing necessary treatment to patients with cancer during the COVID-19 pandemic. In this discussion, moderated by Ted Okon, MBA, a panel of experts discuss the ongoing challenges that oncology providers face as they navigate an evolving healthcare ecosystem, and provide valuable insights on how practices may continue to deliver care in the months ahead.
Read ArticleIn this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.
Read ArticlePharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.
Read ArticleBy Michael Ganio, PharmD; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.
Read ArticleBy Roy Baynes, MD, PhD; Rena Goins; Mark Hagler, MBA; Bruce Wilson; Bryon Wornson; Burt Zweigenhaft, PhD, D.Litt
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.
Read ArticleBy Lucio Gordan, MD; Ted Okon, MBA; Debra Patt, MD, PhD, MBA; Jeff Patton, MD; Burt Zweigenhaft, PhD, D.Litt
Large community care centers remain committed to providing necessary treatment to patients with cancer during the COVID-19 pandemic. In this discussion, moderated by Ted Okon, MBA, a panel of experts discuss the ongoing challenges that oncology providers face as they navigate an evolving healthcare ecosystem, and provide valuable insights on how practices may continue to deliver care in the months ahead.
Read ArticleBy Al B. Benson III, MD; Linda D. Bosserman, MD, FACP; Christian Downs, MHA, JD; Julian Schink, MD; Burt Zweigenhaft, PhD, D.Litt
As a result of the ongoing COVID-19 pandemic, comprehensive cancer care centers have been tasked with significantly altering their strategies for the delivery of care. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discuss some of the changes that have already been implemented at their centers and future considerations for healthcare systems as they focus on providing safe and effective care on the road to recovery.
Read ArticleBy John Fox, MD; Michael Kolodziej, MD; Bryan Loy, MD, MBA; Steven Peskin, MD, MBA, FACP; Burt Zweigenhaft, PhD, D.Litt
Issues surrounding healthcare insurance continue to unfold in light of the recent COVID-19 pandemic. In this discussion, a panel of managed care experts, moderated by Michael Kolodziej, MD, explore strategies for reducing the total cost of care for patients with cancer and addressing the economic and administrative burdens that practices and payers are facing as a result of the crisis.
Read ArticleBy Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Daniel J. Klein; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
Addressing the significant physical and psychosocial needs of patients with cancer during the COVID-19 crisis remains a top priority for healthcare providers. In this discussion, moderated by Elizabeth Franklin, PhD, MSW, a panel of specialists explore efforts underway to advocate for patients who are coping with stress, anxiety, and various economic burdens.
Read ArticleHow does COVID-19 affect the distribution channels that deliver crucial medicine and other supplies for patients with cancer? In ths discussion, thought leaders in the wholesale drug distribution segment focused on the disruption and interventions brought about by the COVID-19 pandemic.
Read Article